STEREOTAXIS ANNOUNCES FIRST PRE-CLINICAL EVALUATION OF A MAGNETICALLY ENABLED INJECTION CATHETER

Stereotaxis, Inc. announced today the successful completion of a proof of concept demonstration of a magnetically enabled endocardial injection catheter developed in collaboration with Biologics Delivery Systems Group, Cordis Corporation. This successful proof of concept demonstration was the first ever automated mapping and therapeutic cell injection procedure and represents a significant breakthrough in the future of adult (non-embryonic) stem cell therapy. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-16-2006/0004362502&EDATE=)